Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials
Clinical trial NCT05100316 · TERMINATED
Trial details
- NCT number
- NCT05100316
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2022-10-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.